There's never a shortage of losers in the stock market. Let's take a closer look at five of this past week's biggest sinkers.
|
Company |
Jan. 13 | Weekly Loss | My Watchlist |
|---|---|---|---|
|
Metabloix |
$2.54 | 51% | Add |
|
WebMD |
$27.76 | 27% | Add |
|
hhgregg |
$10.68 | 23% | Add |
|
Complete Genomics |
$2.86 | 23% | Add |
|
Camelot Info Systems |
$2.18 | 22% | Add |
Source: Barron's.
Metabolix was the market's biggest loser, shedding a little more than half of its value after Archer Daniels Midland backed out of a joint venture for biodegradable plastics.
WebMD called in sick with several different maladies. The medical-website operator announced that its CEO is leaving the company, it was no longer considering a sale of the company, and its outlook for 2012 is looking rather weak.
Shares of hhgregg laid an egg, after the consumer-electronics retailer hosed down its near-term prospects. The chain specializing in big-ticket appliances and gadgetry now is looking to earn no more than $1.15 a share this fiscal year. Its earlier outlook was calling for profitability per share to come in between $1.26 and $1.41.
Complete Genomics was one of the market's biggest winners the prior week, but shares of the genetics specialist went the wrong way this time around after Oppenheimer & Co. downgraded the stock.
Finally we have Camelotgetting lanced a lot, as class action attorneys continue to file lawsuits against the Chinese IT services provider, alleging that Camelot made misleading financial statements before the stock began crashing last year.
It was a rough week for these five stocks. If you want to shake yesterday's losers and ride tomorrow's winners, a new special report reveals The Motley Fool's top stock for 2012. It's free, but only for a limited time, so check it out now.
